摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-aminopropylamino)-5-methylpyridine | 92993-36-7

中文名称
——
中文别名
——
英文名称
2-(3-aminopropylamino)-5-methylpyridine
英文别名
N-(3-aminopropyl)-5-methylpyridin-2-amine;N'-(5-methylpyridin-2-yl)propane-1,3-diamine
2-(3-aminopropylamino)-5-methylpyridine化学式
CAS
92993-36-7
化学式
C9H15N3
mdl
MFCD09864445
分子量
165.238
InChiKey
JWNZOQZHIZZXOY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.444
  • 拓扑面积:
    50.9
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    5-[(6-甲基-3-吡啶基)甲基]-2-(硝基氨基)-4(1H)-嘧啶酮2-(3-aminopropylamino)-5-methylpyridine吡啶 为溶剂, 反应 22.0h, 以50%的产率得到2-[3-(5-methylpyrid-2-ylamino)propylamino]-5-(6-methylpyrid-3-ylmethyl)-4-pyrimidone
    参考文献:
    名称:
    Non-basic histamine H1-antagonists. I. Synthesis and biological evaluation of some substituted 2-(2-pyridylaminoalkylamino) pyrimidones and related compounds
    摘要:
    DOI:
    10.1016/0223-5234(89)90006-8
  • 作为产物:
    描述:
    2-溴-5-甲基吡啶1,3-丙二胺2,2-丙烷二胺氯仿potassium carbonate 作用下, 以 吡啶 为溶剂, 反应 6.0h, 以to give 2-(3-aminopropylamino)-5-methylpyridine as an oil (9.95 g; 60%) which的产率得到2-(3-aminopropylamino)-5-methylpyridine
    参考文献:
    名称:
    Pyridylaminoalkylamine intermediates
    摘要:
    公开了一些吡啶衍生物,它们可用作组胺H.sub.1-拮抗剂。
    公开号:
    US04652650A1
点击查看最新优质反应信息

文献信息

  • Pyridylaminoalkylaminopyrimidones useful as histamine H.sub.1
    申请人:Smith Kline & French Laboratories Limited
    公开号:US04548940A1
    公开(公告)日:1985-10-22
    Pyridine derivatives are disclosed which are useful as histamine H.sub.1 -antagonists.
    已披露用作组胺H.sub.1-拮抗剂的吡啶衍生物。
  • AMINOALCOHOL LIPIDOIDS AND USES THEREOF
    申请人:Mahon Kerry Peter
    公开号:US20110293703A1
    公开(公告)日:2011-12-01
    Aminoalcohol lipidoids are prepared by reacting an amine with an epoxide-terminated compound are described. Methods of preparing aminoalcohol lipidoids from commercially available starting materials are also provided. Aminoalcohol lipidoids may be prepared from racemic or stereochemically pure epoxides. Aminoalcohol lipidoids or salts forms thereof are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems. Given the amino moiety of these aminoalcohol lipidoid compounds, they are particularly suited for the delivery of polynucleotides. Complexes, micelles, liposomes or particles containing the inventive lipidoids and polynucleotide have been prepared. The inventive lipidoids may also be used in preparing microparticles for drug delivery. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.
    本文描述了通过将胺与环氧末端化合物反应制备氨基醇脂质体的方法。还提供了从商业起始材料制备氨基醇脂质体的方法。氨基醇脂质体可以从外消旋或立体化学纯的环氧化合物制备。氨基醇脂质体或其盐形式最好是可生物降解和生物相容的,并可用于各种药物输送系统。鉴于这些氨基醇脂质体化合物的氨基基团,它们特别适用于多核苷酸的输送。已经制备了包含创新脂质体和多核苷酸的复合物、胶束、脂质体或粒子。创新脂质体也可以用于制备药物输送的微粒。鉴于它们能够缓冲其周围环境的pH值,它们在输送不稳定剂方面特别有用。
  • Aminopyrimidinone derivatives as histamine H1-antagonists
    申请人:SMITH KLINE & FRENCH LABORATORIES LIMITED
    公开号:EP0112707A2
    公开(公告)日:1984-07-04
    The present invention provides compounds of formula (1): and pharmaceutically acceptable acid addition salts thererof where R1 is 2- or 3-pyridyl optionally bearing one or two substituents which are the same or different and which are C1-4 alkyl, C1-4 alkoxy, halogen, nitro, cyano or trifluoromethyl; a is 2 to 4; and R2 is phenyl optionally bearing one or two substituents which are the same or different and are halogen, hydroxy, C1-4 alkyl or C1-4 alkoxy or a methylenedioxy group or is 3-pyridyl; N-oxo-3-pyridyl; 6-methyl-3-pyridyl; N-oxo-6-methyl-3-pyridyl; 6-hydroxymethyl-3-pyridyl; 4,6-dimethyl-3-pyridyl; N-oxo-4,6-dimethyl-3-pyridyl; 6-hydroxymethyl-4-methyl-3--pyridyl; 5,6-dimethyl-3-pyridyl; N-oxo-5,6-dimethyl-3-pyridyl; 6-hydroxymethyl-5-methyl-3-pyridyl; 4-pyridyl or N--oxo-4-pyridyl. These compounds are useful as histamine H1-antagonists.
    本发明提供了式(1)化合物: 及其药学上可接受的酸加成盐,其中 R1 是 2-或 3-吡啶基,任选带有一个或两个相同或不同的取代基,这些取代基是 C1-4 烷基、C1-4 烷氧基、卤素、硝基、氰基或三氟甲基; a 是 2 至 4;以及 R2 是苯基,可选择带有一个或两个相同或不同的取代基,它们是卤素、羟基、C1-4 烷基或 C1-4 烷氧基或亚甲基二氧基,或者是 3-吡啶基; N-氧代-3-吡啶基;6-甲基-3-吡啶基;N-氧代-6-甲基-3-吡啶基;6-羟甲基-3-吡啶基;4,6-二甲基-3-吡啶基;N-氧代-4,6-二甲基-3-吡啶基;6-羟甲基-4-甲基-3-吡啶基;5,6-二甲基-3-吡啶基;N-氧代-5,6-二甲基-3-吡啶基;6-羟甲基-5-甲基-3-吡啶基;4-吡啶基或 N-氧代-4-吡啶基。 这些化合物可用作组胺 H1 拮抗剂。
  • IFE, ROBERT J.;CATCHPOLE, KEITH W.;DURANT, GRAHAM J.;GANELLIN, C. ROBIN;H+, EUR. J. MED. CHEM., 24,(1989) N, C. 249-257
    作者:IFE, ROBERT J.、CATCHPOLE, KEITH W.、DURANT, GRAHAM J.、GANELLIN, C. ROBIN、H+
    DOI:——
    日期:——
  • POLY(BETA-AMINO ALCOHOLS), THEIR PREPARATION, AND USES THEREOF
    申请人:Ma Minglin
    公开号:US20130302401A1
    公开(公告)日:2013-11-14
    A new class of poly(beta-amino alcohols) (PBAAs) has been prepared using combinatorial polymerization. The inventive PBAAs may be used in biotechnology and biomedical applications as coatings (such as coatings of films or multilayer films for medical devices or implants), additives, materials, excipients, non-biofouling agents, micropatterning agents, and cellular encapsulation agents. When used as surface coatings, these PBAAs elicited different levels of inflammation, both in vitro and in vivo, depending on their chemical structures. The large chemical diversity of this class of materials allowed us to identify polymer coatings that inhibit macrophage activation in vitro. Furthermore, these coatings reduce the recruitment of inflammatory cells, and reduce fibrosis, following the subcutaneous implantation of carboxylated polystyrene microparticles. These polymers may be used to form polyelectrolyte complex capsules for cell encapsulation. The invention may also have many other biological applications such as antimicrobial coatings, DNA or siRNA delivery, and stem cell tissue engineering.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-